Abstract
The value of an idea in the world of investing is often overestimated, as investors are more interested in the team’s ability to turn the idea into a product or service that meets customers’ needs and wants. While an idea is the starting point, it holds no value until it faces market realities, competitors, regulations, and other factors that shape its worth. Investors look for startups with a robust execution plan, a resilient team, scalability, adaptability, early validation, and a compelling pitch. Scientific results also hold value as a starting point for potential therapies or products, but their ultimate worth depends on successful translation. The key lesson for startups and investors alike is to not overestimate the value of raw ideas or scientific results without considering the execution process’s challenges and requirements.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
